Active substance
Ramipril
- SFDA 5
- US FDA 21
- Health Canada 55
- US price lines 4
- NHS prices 9
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ANGIRAM | 10 mg | Tablet · Oral use | 20 Blister | SAR 41.85 | Generic · Prescription | Aurobindo Pharma Saudi Arabia Limited | Valid |
| ANGIRAM | 5 mg | Tablet · Oral use | 20 Blister | SAR 32.65 | Generic · Prescription | Aurobindo Pharma Saudi Arabia Limited | Valid |
| RAMIPRIL SANDOZ 10MG TABLET | 10 mg | Tablet · Oral use | 20 Blister | SAR 24.75 | NCE · Prescription | HEXAL | Valid |
| RAMIPRIL SANDOZ 2.5MG TABLET | 2.5 mg | Tablet · Oral use | 20 Blister | SAR 13.20 | NCE · Prescription | HEXAL | Valid |
| RAMIPRIL SANDOZ 5MG TABLET | 5 mg | Tablet · Oral use | 20 Blister | SAR 23.40 | NCE · Prescription | HEXAL | Valid |
Indications — CHI Daman Drug Formulary
CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HYPERTENSION; NON-ST WAVE ELEVATED MYOCARDIAL INFARCTION (NSTEMI); SICKLE CELL DISEASE - ALBUMINURIA MANAGEMENT; ST-WAVE ELEVATED MYOCARDIAL INFARCTION (STEMI); SYSTEMIC LUPUS ERYTHEMATOSUS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| RAMIPRIL | 1.25MG; 2.5MG; 10MG | capsule · oral | WATSON LABS | Prescription | 24 Oct 2005 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | LUPIN | Prescription | 9 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | HIKMA PHARMS | Prescription | 18 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | PHARMAZONE | Prescription | 18 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | CHARTWELL MOLECULAR | Prescription | 18 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | COREPHARMA | Prescription | 20 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | ZYDUS PHARMS USA | Prescription | 2 Sep 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | AUROBINDO PHARMA LTD | Prescription | 8 Jun 2011 |
| ALTACE | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | KING PHARMS LLC | Discontinued | 28 Jan 1991 |
| RAMIPRIL | 5MG | capsule · oral | WATSON LABS | Discontinued | 24 Oct 2005 |
| ALTACE | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | KING PFIZER | Discontinued | 27 Feb 2007 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | TEVA PHARMS | Discontinued | 18 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | ACTAVIS ELIZABETH | Discontinued | 18 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | CHARTWELL RX | Discontinued | 18 Jun 2008 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | CIPLA | Discontinued | 7 Aug 2008 |
| RAMIPRIL | 5MG; 10MG | capsule · oral | RANBAXY LABS LTD | Discontinued | 6 Mar 2009 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | tablet · oral | ZYDUS PHARMS USA INC | Discontinued | 24 Sep 2009 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | tablet · oral | NATCO PHARMA | Discontinued | 30 Jun 2011 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | capsule · oral | ACCORD HLTHCARE | Discontinued | 15 Apr 2014 |
| RAMIPRIL | 1.25MG; 2.5MG; 5MG; 10MG | tablet · oral | APOTEX | Discontinued | 2 Dec 2015 |
| VOSTALLY | 1MG/ML | solution · oral | ROSEMONT PHARMS | Discontinued | 23 Jul 2025 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AG-RAMIPRIL | 02477572 | 2.5 MG | CAPSULE · ORAL | ANGITA PHARMA INC. |
| AG-RAMIPRIL | 02477580 | 5 MG | CAPSULE · ORAL | ANGITA PHARMA INC. |
| AG-RAMIPRIL | 02477599 | 10 MG | CAPSULE · ORAL | ANGITA PHARMA INC. |
| ALTACE | 02221829 | 1.25 MG | CAPSULE · ORAL | BAUSCH HEALTH, CANADA INC. |
| ALTACE | 02221837 | 2.5 MG | CAPSULE · ORAL | BAUSCH HEALTH, CANADA INC. |
| ALTACE | 02221845 | 5 MG | CAPSULE · ORAL | BAUSCH HEALTH, CANADA INC. |
| ALTACE | 02221853 | 10 MG | CAPSULE · ORAL | BAUSCH HEALTH, CANADA INC. |
| APO-RAMIPRIL | 02251515 | 1.25 MG | CAPSULE · ORAL | APOTEX INC |
| APO-RAMIPRIL | 02251531 | 2.5 MG | CAPSULE · ORAL | APOTEX INC |
| APO-RAMIPRIL | 02251574 | 5 MG | CAPSULE · ORAL | APOTEX INC |
| APO-RAMIPRIL | 02251582 | 10 MG | CAPSULE · ORAL | APOTEX INC |
| APO-RAMIPRIL | 02325381 | 15 MG | CAPSULE · ORAL | APOTEX INC |
| AURO-RAMIPRIL | 02387387 | 1.25 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AURO-RAMIPRIL | 02387395 | 2.5 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AURO-RAMIPRIL | 02387409 | 5 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AURO-RAMIPRIL | 02387417 | 10 MG | CAPSULE · ORAL | AURO PHARMA INC |
| JAMP RAMIPRIL | 02331128 | 2.5 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| JAMP RAMIPRIL | 02331136 | 5 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| JAMP RAMIPRIL | 02331144 | 10 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| MAR-RAMIPRIL | 02420465 | 2.5 MG | CAPSULE · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-RAMIPRIL | 02420473 | 5.0 MG | CAPSULE · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-RAMIPRIL | 02420481 | 10.0 MG | CAPSULE · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-RAMIPRIL | 02420503 | 15.0 MG | CAPSULE · ORAL | MARCAN PHARMACEUTICALS INC |
| MINT-RAMIPRIL | 02421305 | 2.5 MG | CAPSULE · ORAL | MINT PHARMACEUTICALS INC |
| MINT-RAMIPRIL | 02421313 | 5.0 MG | CAPSULE · ORAL | MINT PHARMACEUTICALS INC |
30 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | RAMIPRIL 1.25 MG CAPSULE | $0.08041 | per EA | 23 Sep 2026 |
| US NADAC | RAMIPRIL 10 MG CAPSULE | $0.07071 | per EA | 23 Sep 2026 |
| US NADAC | RAMIPRIL 2.5 MG CAPSULE | $0.0473 | per EA | 23 Sep 2026 |
| US NADAC | RAMIPRIL 5 MG CAPSULE | $0.05141 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Ramipril 1.25mg capsules | £3.75 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 1.25mg tablets | £2.65 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 10mg capsules | £1.57 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 10mg tablets | £1.05 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 2.5mg capsules | £1.50 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 2.5mg tablets | £1.05 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 2.5mg/5ml oral solution sugar free | £205.80 | 150 ml | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 5mg capsules | £1.51 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Ramipril 5mg tablets | £0.99 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 7 May 2026 ALTACE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Ramipril
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.